BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23623450)

  • 1. Polymorphisms in schizophrenia candidate gene UFD1L may contribute to cognitive deficits.
    Ota VK; Berberian AA; Gadelha A; Santoro ML; Ottoni GL; Matsuzaka CT; Mari JJ; Melaragno MI; Lara DR; Smith MA; Belangero SI; Bressan RA
    Psychiatry Res; 2013 Aug; 209(1):110-3. PubMed ID: 23623450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
    Lopez-Garcia P; Young Espinoza L; Molero Santos P; Marin J; Ortuño Sanchez-Pedreño F
    Psychiatry Res; 2013 Jul; 208(2):118-24. PubMed ID: 23102922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients.
    Bakanidze G; Brandl EJ; Hutzler C; Aurass F; Onken S; Rapp MA; Puls I
    Neuropsychobiology; 2016; 74(1):41-47. PubMed ID: 27798936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic influences on cognitive endophenotypes in schizophrenia.
    Yeo RA; Gangestad SW; Walton E; Ehrlich S; Pommy J; Turner JA; Liu J; Mayer AR; Schulz SC; Ho BC; Bustillo JR; Wassink TH; Sponheim SR; Morrow EM; Calhoun VD
    Schizophr Res; 2014 Jun; 156(1):71-5. PubMed ID: 24768440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
    Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A.
    Van Den Bossche MJ; Docx L; Morrens M; Cammaerts S; Strazisar M; Bervoets C; Smolders S; Depreeuw V; Lenaerts AS; De Rijk P; Del-Favero J; Sabbe BG
    Neuropsychobiology; 2012; 66(3):158-66. PubMed ID: 22948380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saitohin polymorphism and executive dysfunction in schizophrenia.
    Bosia M; Buonocore M; Guglielmino C; Pirovano A; Lorenzi C; Marcone A; Bramanti P; Cappa SF; Aguglia E; Smeraldi E; Cavallaro R
    Neurol Sci; 2012 Oct; 33(5):1051-6. PubMed ID: 22187337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
    Donohoe G; Walters J; Morris DW; Quinn EM; Judge R; Norton N; Giegling I; Hartmann AM; Möller HJ; Muglia P; Williams H; Moskvina V; Peel R; O'Donoghue T; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Corvin A
    Arch Gen Psychiatry; 2009 Oct; 66(10):1045-54. PubMed ID: 19805695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha -1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls.
    Xiu MH; Man LJ; Wang D; Du X; Yin G; Zhang Y; Tan YL; Chen N; Chen S; Teixeira AL; Cassidy RM; Soares JC; Zhang XY
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):379-387. PubMed ID: 29633506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.
    Prasad KM; Almasy L; Gur RC; Gur RE; Pogue-Geile M; Chowdari KV; Talkowski ME; Nimgaonkar VL
    Schizophr Bull; 2010 Sep; 36(5):983-90. PubMed ID: 19282471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UFD1L rs5992403 polymorphism is associated with age at onset of schizophrenia.
    Ota VK; Belangero SI; Gadelha A; Bellucco FT; Christofolini DM; Mancini TI; Ribeiro-dos-Santos AK; Santos SE; Mari Jde J; Bressan RA; Melaragno MI; Smith Mde A
    J Psychiatr Res; 2010 Nov; 44(15):1113-5. PubMed ID: 20471029
    [No Abstract]   [Full Text] [Related]  

  • 14. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia.
    Zhang C; Cai J; Zhang J; Li Z; Guo Z; Zhang X; Lu W; Zhang Y; Yuan A; Yu S; Fang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():110-5. PubMed ID: 24361380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia.
    Bosia M; Anselmetti S; Bechi M; Lorenzi C; Pirovano A; Cocchi F; Buonocore M; Bramanti P; Smeraldi E; Cavallaro R
    Psychiatry Res; 2011 Jul; 188(2):187-90. PubMed ID: 21194755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls.
    Wirgenes KV; Djurovic S; Sundet K; Agartz I; Mattingsdal M; Athanasiu L; Melle I; Andreassen OA
    Schizophr Res; 2010 Sep; 122(1-3):31-7. PubMed ID: 20605701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.
    Koide T; Banno M; Aleksic B; Yamashita S; Kikuchi T; Kohmura K; Adachi Y; Kawano N; Kushima I; Nakamura Y; Okada T; Ikeda M; Ohi K; Yasuda Y; Hashimoto R; Inada T; Ujike H; Iidaka T; Suzuki M; Takeda M; Iwata N; Ozaki N
    PLoS One; 2012; 7(5):e36836. PubMed ID: 22649501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function.
    LeBlanc M; Kulle B; Sundet K; Agartz I; Melle I; Djurovic S; Frigessi A; Andreassen OA
    J Psychiatr Res; 2012 Feb; 46(2):271-8. PubMed ID: 22126837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
    Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
    Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.